TYAVANAGIMATT SHANTHAKUMAR R.,WEIMERS WILLIAM C.,O&rsquo,NEILL MICHAEL H.,SWEETAPPLE GARY,HRUBY DENNIS E.,NELSON DYLAN,MCCLOUGHAN KELLEY A.,BOLKEN TOVE C.,STONE MELIALANI A.C.L.,O&rsquoNEILL MICHAEL H.
申请号：
NZ60257811
公开号：
NZ602578A
申请日:
2011.03.23
申请国别(地区):
NZ
年份:
2014
代理人:
摘要：
The disclosure relates to polymorph forms of 4-trifluoromethyl -N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f] isoindol-2(1H)-yl)-benzamide (named ST-246) as well as their methods of synthesis and pharmaceutical compositions. These polymorph forms of said compound are suitable for treating Orthopoxvirus infections and eczema vaccinatum.
